Intraperitoneal Chemotherapy

This publication has 36 references indexed in Scilit:

• Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
  Journal of Clinical Oncology, 2001
• Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up
  Gynecologic Oncology, 2000
• Intraperitoneal chemotherapy
  Critical Reviews in Oncology/Hematology, 1999
• Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
  Gynecologic Oncology, 1998
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity
  Critical Reviews in Oncology/Hematology, 1993
• Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.
  Journal of Clinical Oncology, 1991
• Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factors
  American Journal of Obstetrics and Gynecology, 1988
• Clinical pharmacology of intraperitoneal cisplatin
  Gynecologic Oncology, 1985
• USE OF NITROGEN MUSTARD IN TREATMENT OF SEROUS EFFUSIONS OF NEOPLASTIC ORIGIN
  JAMA, 1955